Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe

September 1, 2010 11:35 am | by Bio-Medicine.Org | News | Comments

LEWISBERRY, Pa., Sept. 1 /- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS, ASX: UNS), today announced that its Unitract™ Tuberculin (TB) Syringe has received  510(k) market clearance from the U.S. Food and Drug Administration (FDA).   The Unitract™ TB...

TOPICS:

Metformin May Protect Against Lung Cancer

September 1, 2010 11:33 am | by AACR | News | Comments

PHILADELPHIA — Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI).

TOPICS:

Federal Register: Public Workshop on Medical Devices and Nanotechnology: Manufacturing, Characterization, and Biocompatibility Considerations; Correction.

September 1, 2010 11:31 am | by U.S. Food & Drug Administration | News | Comments

The FDA is correcting a notice that appeared in the Federal Register of August 23, 2010 (75 FR 51829). The notice announced the public workshop entitled 'Medical Devices & Nanotechnology: Manufacturing, Characterization, and Biocompatibility...

TOPICS:
Advertisement

Federal Register: Medical Device User Fee Act; Public Meeting; Request for Comments; Amendment of Notice

September 1, 2010 11:31 am | by U.S. Food & Drug Administration | News | Comments

The FDA is announcing an amendment to the notice of a public meeting on the reauthorization of the medical device user fee program. This meeting was announced in the Federal Register of August 13, 2010 (75 FR 49502). The amendment is being made to...

TOPICS:

Tygacil (tigecycline): Label Change - Increased Mortality Risk

September 1, 2010 11:30 am | by U.S. Food & Drug Administration | News | Comments

Healthcare professionals should consider alternatives to Tygacil in patients with severe infections.

TOPICS:

‘ZPrinted’ 3D Models Help Improve Oral Surgery

September 1, 2010 11:17 am | by Z Corporation | Articles | Comments

Planmeca Oy, the largest privately owned high-tech dental equipment maker, is using Z Corporation 3D printing technology to transform maxillofacial surgery, leading to shorter procedures, reduced hospital stays, lower health-care costs and improved patient outcomes.

TOPICS:

Omnicare buys Continuing Care Rx

September 1, 2010 9:45 am | by The Associated Press | News | Comments

Omnicare Inc., which dispenses drugs to nursing homes and long-term care facilities, said Wednesday it bought privately held Continuing Care Rx for an undisclosed amount.Continuing Care, based in Harrisburg, Pa., provides pharmacy services to residents of long-term care and other facilities in...

LHC Group acquires home health agency

September 1, 2010 8:45 am | by The Associated Press | News | Comments

Home health provider LHC Group Inc. says it has acquired the assets of a home health agency in Harrodsburg, Ky.Terms of the deal with James B. Haggin Memorial Hospital were not revealed. Lafayette-based LHC Group will take over the operations of Haggin Home Health. The agency will be renamed...

Advertisement

Results From Investigator-Sponsored Trials Presented at SSIEM Conference

September 1, 2010 7:31 am | by Bio-Medicine.Org | News | Comments

NOVATO, Calif., Sept. 1 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that results from investigator-sponsored studies on Kuvan (sapropterin dihydrochloride) are being presented at the 2010 Annual Symposium of the Society for The Study of Inborn Errors of Metabolism...

TOPICS:

Radiated Test System Provides More Flexibility

September 1, 2010 6:38 am | Product Releases | Comments

Teseq Inc., a leading developer and provider of instrumentation and systems for EMC emission and immunity testing, has improved its ITS 6006 (immunity test system) for radiated EMC immunity testing...

FoldRx to be acquired by Pfizer

September 1, 2010 6:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge small molecule therapeutics firm FoldRx Pharmaceuticals Inc. is going to be acquired by pharmaceutical giant Pfizer Inc. as part of the latter company’s overall strategy to increase its pipeline of drugs to treat rare diseases.

TOPICS:

<i>Tech across New England: </i>ProThera Biologics takes holistic approach to treating inflammation

September 1, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Mass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. ProThera Biologics develops technology centered on a protein in the blood that regulates the immune system and is the key to controlling sepsis...

TOPICS:

PerkinElmer pulls in $500M from sales of IDS unit

September 1, 2010 6:32 am | by Mass High Tech: The Journal of New England Technology | News | Comments

In its latest move of adding or subtracting business lines, PerkinElmer Inc. reports it has agreed to sell its Illumination and Detection Solutions (IDS) business to Veritas Capital Fund III LP, a New York-based private equity firm, for approximately $500 million in cash.

TOPICS:

Touchscreen TFT LCDs Feature Thin Profile

September 1, 2010 6:31 am | Product Releases | Comments

InfoVue TFT LCDs come in both touch screen and standard formats and feature an extended temperature range, LED backlighting for high contrast, and a thin profile starting at an industry-leading 3.0 mm.

Die Cut Electrical Insulations Made From Flame Retardant Polypropylene

September 1, 2010 6:23 am | Product Releases | Comments

These custom die cut electrically insulated parts, that provide high dielectric strength, are flame retardant per UL94V-0 and are RoHS compliant.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading